Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
2.
Article in English | IMSEAR | ID: sea-85842

ABSTRACT

An interesting case of Non-Hodgkins lymphoma presenting as pure red cell aplasia is being reported. Even though acquired pure red cell aplasia is not uncommon, lymphoma presenting as pure red cell aplasia is very rare. The patient responded to COP treatment and red cell transfusion and is on regular follow up. This appears to be the first report of such an association in Indian literature.


Subject(s)
Adolescent , Female , Humans , Lymphoma, Non-Hodgkin/complications , Red-Cell Aplasia, Pure/etiology
3.
Article in English | IMSEAR | ID: sea-94591

ABSTRACT

This is to highlight the rare complication of pancytopenia following an attack of chickenpox and the favourable response to high dose intravenous immunoglobulin. We are hereby postulating the cause of this refractory pancytopenia as viral antibody mediated event and hence the response to intravenous immunoglobulin.


Subject(s)
Adolescent , Chickenpox/complications , Humans , Immunoglobulins, Intravenous/administration & dosage , Male , Pancytopenia/etiology
4.
Article in English | IMSEAR | ID: sea-89045

ABSTRACT

We are reporting a young lady with protracted deep vein thrombosis of her left leg which turned out to be antiphospholipid (anticardiolipin) antibody syndrome of ANA positive systemic lupus erythematosus. Lupus anticoagulant was demonstrated by prolongation of activated partial thromboplastin time and Russell's viper venom time. She had no anti-thrombin III deficiency.


Subject(s)
Adolescent , Adrenal Cortex Hormones/therapeutic use , Anticoagulants/therapeutic use , Antiphospholipid Syndrome/diagnosis , Azathioprine/therapeutic use , Female , Follow-Up Studies , Humans , Lupus Erythematosus, Systemic/complications , Thrombophlebitis/drug therapy , Time Factors
5.
Article in English | IMSEAR | ID: sea-88645

ABSTRACT

We report response in anaemia and wellbeing of a lady with chronic renal disease treated with recombinant human erythropoietin 5000 units thrice weekly. Without any blood transfusions, the patient's haematocrit improved (20% to 35%) and a subjective improvement in wellbeing and appetite was noted. This drug seems to be a breakthrough in the management of anaemia of chronic renal diseases, including end stage renal disease, avoiding the risks of repeated blood transfusions.


Subject(s)
Anemia/drug therapy , Erythropoietin/therapeutic use , Female , Hematocrit , Humans , Kidney Failure, Chronic/complications , Middle Aged , Recombinant Proteins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL